Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses

Coronary Artery Disease

Volumn 25, Issue 2, 2014, Pages 172-185

  Di Vito, Luca ^a,b   Yoon, Joo Heung ^d   Kato, Koji ^e   Yonetsu, Taishi ^e   Vergallo, Rocco ^e   Costa, Marco ^f   Bezerra, Hiram G ^f   Arbustini, Eloisa ^c   Narula, Jagat ^g   Crea, Filippo ^a   Prati, Francesco ^b   Jang, Ik Kyung ^e  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

optical coherence tomography; plaque rupture; stent; thin cap fibroatheroma

Indexed keywords

CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; HUMANS; HYPERPLASIA; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STENTS; TERMINOLOGY AS TOPIC; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84894101218     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000072     Document Type: Review

References (89)

1. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31:401-415
2. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol 2012; 59:1058-1072
3. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, et al. Expert review document part 2: Methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012; 33:2513-2520
4. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111:1551-1555
5. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-st-segment elevation acute coronary syndrome: An optical coherence tomography study. Eur Heart J 2009; 30:1348-1355
6. Yonetsu T, Kakuta T, Lee T, Takahashi K, Kawaguchi N, Yamamoto G, et al. In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011; 32: 1251-1259
7. Suzuki N, Guagliumi G, Bezerra HG, Sirbu V, Rosenthal N, Musumeci G, et al. The impact of an eccentric intravascular imagewire during coronary optical coherence tomography imaging. EuroIntervention 2011; 6: 963-969
8. Guagliumi G, Bezerra HG, Sirbu V, Ikejima H, Musumeci G, Biondi-Zoccai G, et al. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv 2012; 5:30-38
9. Yoon JH, Di Vito L, Moses JW, Fearon WF, Yeung AC, Zhang S, et al. Feasibility and safety of the second-generation, frequency domain optical coherence tomography (FD-OCT): A multicenter study. J Invasive Cardiol 2012; 24:206-209
10. Ozaki Y, Kitabata H, Tsujioka H, Hosokawa S, Kashiwagi M, Ishibashi K, et al. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J 2012; 76: 922-927
11. Mizukoshi M, Imanishi T, Tanaka A, Kubo T, Liu Y, Takarada S, et al. Clinical classification and plaque morphology determined by optical coherence tomography in unstable angina pectoris. Am J Cardiol 2010; 106:323-328
12. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Non-culprit plaques in patients with acute coronary syndromes (ACS) have more vulnerable features compared to those with non-ACS: A 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012; 5:430-440
13. Kubo T, Xu C, Wang Z, van Ditzhuijzen NS, Bezerra HG. Plaque and thrombus evaluation by optical coherence tomography. Int J Cardiovasc Imaging 2011; 27:289-298
14. Waller BF. Anatomy, histology, and pathology of the major epicardial coronary arteries relevant to echocardiographic imaging techniques. J Am Soc Echocardiogr 1989; 2:232-252
15. Yonetsu T, Kakuta T, Lee T, Takayama K, Kakita K, Iwamoto T, et al. Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography. Eur Heart J 2010; 31:1608-1615
16. Uemura S, Ishigami KI, Soeda T, Okayama S, Sung JH, Nakagawa H, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 2011; 33:78-85
17. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002; 106:1640-1645
18. Lee T, Kakuta T, Yonetsu T, Takahashi K, Yamamoto G, Iesaka Y, et al. Assessment of echo-Attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation. JACC Cardiovasc Interv 2011; 4:483-491
19. Fujii K, Kawasaki D, Masutani M, Okumura T, Akagami T, Sakoda T, et al. OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. JACC Cardiovasc Imaging 2010; 3:168-175
20. Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation. Circ J 2012; 76:698-703
21. Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H, et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome an optical coherence tomography study. JACC Cardiovasc Interv 2011; 4:76-82
22. Feng T, Yundai C, Lian C, Zhijun S, Changfu L, Jun G, et al. Assessment of coronary plaque characteristics by optical coherence tomography in patients with diabetes mellitus complicated with unstable angina pectoris. Atherosclerosis 2010; 213:482-485
23. Yonetsu T, Kakuta T, Lee T, Takahashi K, Yamamoto G, Iesaka Y, et al. Impact of plaque morphology on creatine kinase-mb elevation in patients with elective stent implantation. Int J Cardiol 2011; 146:80-85
24. Tian J, Hou J, Xing L, Kim SJ, Yonetsu T, Kato K, et al. Does neovascularization predict response to statin therapy? Optical coherence tomography study. Int J Cardiol 2012; 158:469-470
25. Wang Z, Chamie D, Bezerra HG, Yamamoto H, Kanovsky J, Wilson DL, et al. Volumetric quantification of fibrous caps using intravascular optical coherence tomography. Biomed Opt Express 2012; 3:1413-1426
26. Bezerra HG, Attizzani GF, Costa MA. Three-dimensional imaging of fibrous cap by frequency-domain optical coherence tomography. Catheter Cardiovasc Interv 2013; 81:547-549
27. Rathore S, Terashima M, Matsuo H, Kinoshita Y, Kimura M, Tsuchikane E, et al. Association of coronary plaque composition and arterial remodelling: A optical coherence tomography study. Atherosclerosis 2012; 221:405-415
28. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: A clinicopathological study. Circulation 2010; 122:2505-2513
29. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007; 50:933-939
30. Ozaki Y, Okumura M, Ismail TF, Motoyama S, Naruse H, Hattori K, et al. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J 2011; 32:2814-2823
31. Kubo T, Ino Y, Tanimoto T, Kitabata H, Tanaka A, Akasaka T. Optical coherence tomography imaging in acute coronary syndromes. Cardiol Res Pract 2011; 2011:312978
32. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 2009; 55:26-32
33. Kim SJ, Lee H, Kato K, Yonetsu T, Xing L, Zhang S, et al. Reproducibility of in vivo measurements for fibrous cap thickness and lipid arc by oct. JACC Cardiovasc Imaging 2012; 5:1072-1074
34. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47:C13-C18
35. Porto I, Di Vito L, Burzotta F, Biasucci LM, Crea F. Superficial calcified nodules and post-stenting micro-dissections imaged through 3-dimensional optical coherence tomography. Int J Cardiol 2012; 158:62-64
36. Niccoli G, Giubilato S, Di Vito L, Leo A, Cosentino N, Pitocco D, et al. Severity of coronary atherosclerosis in patients with a first acute coronary event: A diabetes paradox. Eur Heart J 2013; 34:729-741
37. Karanasos A, Ligthart JM, Witberg KT, Regar E. Calcified nodules: An underrated mechanism of coronary thrombosis? JACC Cardiovasc Imaging 2012; 5:1071-1072
38. Nakano M, Otsuka F, Virmani R. Letter by nakano et al regarding article,'optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation'. Circulation 2011; 124:e954; author reply e955
39. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003; 107:113-119
40. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004; 44:972-979
41. Tahara S, Morooka T, Wang Z, Bezerra HG, Rollins AM, Simon DI, et al. Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta. Arterioscler Thromb Vasc Biol 2012; 32:1150-1157
42. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90:775-778
43. Brezinski ME. Optical coherence tomography for identifying unstable coronary plaque. Int J Cardiol 2006; 107:154-165
44. Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, Kutys B, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009; 53:1517-1527
45. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: An optical coherence tomography study. Circulation 2008; 118:2368-2373
46. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93:1354-1363
47. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, et al. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: Insights into plaque erosion. Arterioscler Thromb Vasc Biol 2002; 22: 1642-1648
48. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82:269-272
49. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013; 62:1748-1758
50. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Onuma Y, Garcia-Garcia HM, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: A systematic quantitative approach. Heart 2009; 95:1913-1919
51. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: An optical coherence tomography-based natural history study. Eur Heart J 2010; 31:1470-1476
52. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97:1713-1717
53. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012; 5:12-20
54. Gutierrez-Chico JL, Wykrzykowska J, Nuesch E, van Geuns RJ, Koch KT, Koolen JJ, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: Sequential assessment with optical coherence tomography. Circ Cardiovasc Interv 2012; 5:20-29
55. Gomez-Lara J, Brugaletta S, Farooq V, Onuma Y, Diletti R, Windecker S, et al. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. JACC Cardiovasc Interv 2011; 4:1271-1280
56. Porto I, Di Vito L, Burzotta F, Niccoli G, Trani C, Leone AM, et al. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequencydomain optical coherence tomography. Circ Cardiovasc Interv 2012; 5:89-96
57. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, et al. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with diabetes mellitus) trial. JACC Cardiovasc Interv 2011; 4:310-316
58. Takano M, Murakami D, Yamamoto M, Kurihara O, Murai K, Inami T, et al. Sixmonth follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: Comparison with paclitaxel-eluting stents. Int J Cardiol 2013; 166:181-186
59. Kim JS, Jang IK, Fan C, Kim TH, Park SM, Choi EY, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: The ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009; 2:1240-1247
60. Mehanna EA, Attizzani GF, Kyono H, Hake M, Bezerra HG. Assessment of coronary stent by optical coherence tomography, methodology and definitions. Int J Cardiovasc Imaging 2011; 27:259-269
61. Fedele S, Biondi-Zoccai G, Kwiatkowski P, Di Vito L, Occhipinti M, Cremonesi A, et al. Reproducibility of coronary optical coherence tomography for lumen and length measurements in humans (The CLI-VAR [Centro per la Lotta contro L'infarto-VARiability] study). Am J Cardiol 2012; 110:1106-1112
62. Tsutsui H, Schoenhagen P, Crowe TD, Klingensmith JD, Vince DG, Nissen SE, et al. Influence of coronary pulsation on volumetric intravascular ultrasound measurements performed without ECG-gating. Validation in vessel segments with minimal disease. Int J Cardiovasc Imaging 2003; 19:51-57
63. De Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (music study). Eur Heart J 1998; 19:1214-1223
64. Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, Tamburino C, et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: The Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 2012; 8:823-829
65. Imola F, Mallus MT, Ramazzotti V, Manzoli A, Pappalardo A, Di Giorgio A, et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention 2010; 6:575-581
66. Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drugeluting stents assessed by optical coherence tomography. Int J Cardiol 2009; 134:180-188
67. Miyoshi N, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. 6-month follow-up. Circ J 2010; 74:903-908
68. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, et al. Long-term follow-up of neointimal coverage of sirolimus-eluting stents - evaluation with optical coherence tomography. Circ J 2009; 73:2300-2307
69. Tanigawa J, Barlis P, Di Mario C. Intravascular optical coherence tomography: Optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 2007; 3:128-136
70. Gutierrez-Chico JL, Regar E, Nuesch E, Okamura T, Wykrzykowska J, di Mario C, et al. Delayed coverage in malapposed and side-branch struts with respect to well-Apposed struts in drug-eluting stents: In vivo assessment with optical coherence tomography. Circulation 2011; 124:612-623
71. Kyono H, Guagliumi G, Sirbu V, Rosenthal N, Tahara S, Musumeci G, et al. Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations. EuroIntervention 2010; 6:69-77
72. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967
73. Miyazaki S, Hiasa Y, Takahashi T, Yano Y, Minami T, Murakami N, et al. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis. Circ J 2012; 76:398
74. Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, et al. Major determinants for the uncovered stent struts on optical coherence tomography after drugeluting stent implantation. Int J Cardiovasc Imaging 2012; 28:714
75. Kim JS, Hong MK, Fan C, Kim TH, Shim JM, Park SM, et al. Intracoronary thrombus formation after drug-eluting stents implantation: Optical coherence tomographic study. Am Heart J 2010; 159:278-283
76. Papayannis AC, Abdel-Karim AR, Mahmood A, Rangan BV, Makke LB, Banerjee S, et al. Association of coronary lipid core plaque with intrastent thrombus formation: A near-infrared spectroscopy and optical coherence tomography study. Catheter Cardiovasc Interv 2013; 81:488-493
77. Kawamori H, Shite J, Shinke T, Otake H, Sawada T, Kato H, et al. The ability of optical coherence tomography to monitor percutaneous coronary intervention: Detailed comparison with intravascular ultrasound. J Invasive Cardiol 2010; 22:541-545
78. Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: A harmonizing outcomes with revascularization and stents in acute myocardial infarction (horizons-Ami) substudy. Circ Cardiovasc Interv 2011; 4:239-247
79. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158:284-293
80. Capodanno D, Prati F, Pawlowsky T, Ramazzotti V, Albertucci J, La Manna A, et al. Clearwayrx system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (coctail): Study rationale and design. J Cardiovasc Med (Hagerstown) 2010; 11:130-136
81. Abtahian F, Yonetsu T, Vergallo R, Jia H, Kato K, Tian J, et al. Ticagrelor immediately prior to stenting is associated with smaller residual thrombus in patients with acute coronary syndrome. Int J Cardiol 2013; 168: 3099-4101
82. Alfonso F, Paulo M, Dutary J. Endovascular imaging of angiographically invisible spontaneous coronary artery dissection. JACC Cardiovasc Interv 2012; 5:452-453
83. Yamamoto M, Takano M, Murakami D, Inami T, Kimata N, Inami S, et al. Optical coherence tomography analysis for restenosis of drug-eluting stents. Int J Cardiol 2011; 146:100-103
84. Kim K, Gu MB, Kang DH, Park JW, Song IH, Jung HS, et al. High-sensitivity detection of oxytetracycline using light scattering agglutination assay with aptasensor. Electrophoresis 2010; 31:3115-3120
85. Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D, et al. Qualitative assessment of neointimal tissue after drug-eluting stent implantation: Comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 2011; 161:367-372
86. Lee SJ, Kim BK, Kim JS, Ko YG, Choi D, Jang Y, et al. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: An optical coherence tomography study. Clin Cardiol 2011; 34:633-639
87. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drugeluting stent implantation. Circulation 2011; 123:2954-2963
88. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: A retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 2012; 5: 660-666
89. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol 2012; 110:933-939